Clinical Coordinator
The University of Arizona Cancer Center
Tucson, AZ
Amina Ahmed, MD, Paula Anastasia, RN, MN, AOCN, and Ali McBride, PharmD, describe their experiences in the use of niraparib, olaparib, and rucaparib as first-line maintenance therapy in ovarian cancer.